4.2 USD
+0.03 (+0.72%)
ChartMill assigns a Buy % Consensus number of 80% to NEUP. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 9.96. This target is 137.19% above the current price.
- NEUP was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NEUP.
- In the previous month the buy percentage consensus was at a similar level.
- NEUP was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-11 | Maxim Group | Maintains | Buy -> Buy |
| 2025-08-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
NEUPHORIA THERAPEUTICS INC / NEUP FAQ
What is the price target for NEUP stock?
9 analysts have analysed NEUP and the average price target is 9.96 USD. This implies a price increase of 137.19% is expected in the next year compared to the current price of 4.2.
What is the consensus rating for NEUPHORIA THERAPEUTICS INC (NEUP) stock?
The consensus rating for NEUPHORIA THERAPEUTICS INC (NEUP) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for NEUP stock?
The number of analysts covering NEUPHORIA THERAPEUTICS INC (NEUP) is 9.